Is there any effect of fetal gender on the markers of first trimester Down's syndrome screening?

G. Ajayi
DOI: https://doi.org/10.1055/S-0029-1222860
2009-04-01
Clinical and Experimental Obstetrics & Gynecology
Abstract:INTRODUCTION At present, the most effective trisomy 21-screening method is the estimate of risk combining maternal age, fetal nuchal translucency, beta-hCG and pregnancy-associated PAPP-A. OBJECTIVE The aim of this study was to investigate the possible effect of fetal gender in first trimester Down's syndrome screening markers. DESIGN Retrospective study. SETTING Prenatal Diagnosis Centre in a tertiary hospital in Lagos. METHODS Of a total of 350 pregnancies in which fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A were performed were included in this study. These markers were investigated to see if they differed on the basis of fetal gender. RESULTS PAPP-A levels were higher in female fetuses although the difference was not statistically significant. Nuchal translucency was 0.099 mm more in male fetuses. CONCLUSION The results suggest that first trimester markers differ on gender but are of no clinical significance, confirming the result of other authors.
What problem does this paper attempt to address?